These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF. Oncogene; 1995 Feb 02; 10(3):415-22. PubMed ID: 7845666 [Abstract] [Full Text] [Related]
3. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. Sakamoto Y, Yoshida M, Semba K, Hunter T. Oncogene; 1997 Oct 23; 15(17):2001-12. PubMed ID: 9366517 [Abstract] [Full Text] [Related]
4. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Cook DM, Hinkes MT, Bernfield M, Rauscher FJ. Oncogene; 1996 Oct 17; 13(8):1789-99. PubMed ID: 8895526 [Abstract] [Full Text] [Related]
6. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher FJ. Oncogene; 1991 Dec 17; 6(12):2339-48. PubMed ID: 1662794 [Abstract] [Full Text] [Related]
7. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Zhang X, Xing G, Saunders GF. Anticancer Res; 1999 Dec 17; 19(3A):1641-8. PubMed ID: 10470095 [Abstract] [Full Text] [Related]
8. Functional properties of WT1. Haber DA, Englert C, Maheswaran S. Med Pediatr Oncol; 1996 Nov 17; 27(5):453-5. PubMed ID: 8827073 [Abstract] [Full Text] [Related]
9. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. Cancer Res; 1995 Oct 15; 55(20):4540-3. PubMed ID: 7553624 [Abstract] [Full Text] [Related]
10. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor. Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF. Clin Cancer Res; 1997 Dec 15; 3(12 Pt 2):2571-80. PubMed ID: 9815658 [Abstract] [Full Text] [Related]
11. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study. Nurmemmedov E, Yengo RK, Uysal H, Karlsson R, Thunnissen MM. Biophys Chem; 2009 Dec 15; 145(2-3):116-25. PubMed ID: 19853363 [Abstract] [Full Text] [Related]
12. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ, van der Eb AJ, Jochemsen AG. Oncogene; 1996 Feb 01; 12(3):537-46. PubMed ID: 8637710 [Abstract] [Full Text] [Related]
13. Wilms tumor and the WT1 gene. Lee SB, Haber DA. Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525 [Abstract] [Full Text] [Related]
14. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG. Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497 [Abstract] [Full Text] [Related]
15. The role of Wilms' tumor genes. Hirose M. J Med Invest; 1999 Aug 10; 46(3-4):130-40. PubMed ID: 10687307 [Abstract] [Full Text] [Related]
16. Interaction of human polyomavirus BK with the tumor-suppressor protein p53. Shivakumar CV, Das GC. Oncogene; 1996 Jul 18; 13(2):323-32. PubMed ID: 8710371 [Abstract] [Full Text] [Related]
19. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Little MH, Holmes G, Pell L, Caricasole A, Duarte A, Law M, Ward A, Wainwright B. Oncogene; 1996 Oct 03; 13(7):1461-9. PubMed ID: 8875984 [Abstract] [Full Text] [Related]